Lipum’s GMP production of SOL-116 successful

Press release: Umeå, February 24, 2022. Lipum AB (publ) reports that the GMP manufacturing of SOL-116 has been successful and the drug product is now ready for aseptic fill and finish before use in clinical trials.

The release as fetched from its publisher. lipum.se ↗